ClinicalTrials.gg
CompletedNCT07477834Updated Mar 17, 2026

Assessing the Health Impact of Indoor Air Purification Using Health Data Obtained From Apple Watch Wearers

An interventional study of Real Filtration and Sham Filtration in Air Pollution Exposure, Heart Rate and Resting Heart Rate, sponsored by New York University Abu Dhabi. Completed at 1 site in United Arab Emirates. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by New York University Abu Dhabi · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Feb 2025, registered Mar 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This study aims to use the Apple Watch health metrics to assess short-term physiological responses in a randomized, double-blind, crossover real-world indoor purification intervention.

Read the detailed description

Fine particulate matter (PM2.5) poses significant health risks. While indoor air purification is a proven mitigation approach, most studies have used medical devices with limited usability and practicality. Thus, this study aims to use the Apple Watch health metrics to assess short-term physiological responses in a randomized, double-blind, crossover real-world indoor purification intervention with the IQAir Atem X, the first of its kind in the UAE.

The study aims to recruit 42 healthy, non-smoking young adults to undergo two 2-week interventions (real and sham filters), separated by a 1-week washout, at the New York University Abu Dhabi campus. Collected Apple Watch metrics include: heart rate, heart rate variability, daily resting heart rate, sleep respiratory rate, blood oxygen saturation, and sleep stages durations. Daily time-location surveys enable personal PM2.5 exposure estimation from fixed-site sensors. Physiological outcomes and their associations with filtration and PM2.5 exposure are analyzed with paired tests and linear mixed-effect regression models.

02

Conditions studied

  • Air Pollution Exposure
  • Heart Rate
  • Resting Heart Rate
  • HRV
  • SpO2
  • Respiratory Rate
  • Sleep

Keywords

  • Indoor Air Purification
  • Apple Watch
  • Digital Health Research
03

In context

Lead sponsor

New York University Abu Dhabi is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Own an Apple Watch Series 6 or above
  • Own an iPhone
  • iPhone and Apple Watch updated to the latest software versions (iOS 18 and watchOS 11, as of January 2025) to ensure consistent and latest algorithms for measuring health
  • Age range: 18 - 40
  • Non-smoker, defined as never smoke in life or have stopped smoking for at least one year before the start of the study

Exclusion criteria

Exclusion Criteria:

  • Own a Apple Watch sold by Apple in the United States on or after January 18, 2024 which does not support SpO2 measurements. These are indicated with part numbers ending in LW/A.
  • Own or currently use an air quality monitor that can measure particulate matter
  • Own or currently use an air purifier (humidifier or scent diffuser is fine)
  • Any known pre-existing conditions: asthma, diabetes, obesity ( > 30), or chronic cardiorespiratory disease
  • Taking any medications that might affect the heart and lung function
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    Real filtration first, followed by sham filtration

    Participants were randomly assigned to begin with either the real filter or sham filter, before switching halfway into the study. This group first received real air filtration for 2 weeks, followed by a 1-week washout period, and then 2 weeks of sham filtration.

    Behavioral: Real Filtration · Behavioral: Sham Filtration

  • Placebo comparator
    Sham filtration first, followed by active filtration

    Participants were randomly assigned to begin with either the real filter or sham filter, before switching halfway into the study. This group first received sham filtration for 2 weeks, followed by a 1-week washout period, and then 2 weeks of real filtration.

    Behavioral: Real Filtration · Behavioral: Sham Filtration

Interventions

  • BehavioralReal Filtration

    IQAir Atem X purifier with real filter (HyperHEPA) which is designed to remove PM2.5

  • BehavioralSham Filtration

    IQAir Atem X purifier with sham filter which does not filter any PM2.5. When installed inside the purifiers, the sham filter produced the same appearance and sound as the real one, making the two interventions indistinguishable to participants.

06

What researchers measure

Primary outcomes

  1. Heart Rate Changes

    Instantaneous heart rate is measured by the Apple Watch in the background throughout the two interventions. Values are compared between the real and sham filtration to assess the effect of air purification. Unit: number of heartbeats per minute

    Time frame: During each 2-week intervention (real and sham filtration); 1-week washout period is excluded

  2. Daily Resting Heart Rate Changes

    Resting heart rate is the daily average heart rate during rest measured by the Apple Watch in the background, reported by the Apple Watch as one single aggregated value per day, throughout the two interventions. Values are compared between the real and sham filtration to assess the effect of air purification. Unit: number of heartbeats per minute

    Time frame: During each 2-week intervention (real and sham filtration); 1-week washout period is excluded

  3. Heart Rate Variability Changes

    Heart rate variability, variation in time between consecutive heartbeats, is measured by the Apple Watch in the background throughout the two interventions. The Apple Watch specifically measures the Standard Deviation of NN intervals (SDNN). Values are compared between the real and sham filtration to assess the effect of air purification. Unit: millisecond

    Time frame: During each 2-week intervention (real and sham filtration); 1-week washout period is excluded

  4. Oxygen Saturation Changes

    Percentage of blood oxygen saturation is measured by the Apple Watch in the background throughout the two interventions. Values are compared between the real and sham filtration to assess the effect of air purification. Unit: %

    Time frame: During each 2-week intervention (real and sham filtration); 1-week washout period is excluded

  5. Sleep Respiratory Rate Changes

    Respiratory rate is measured by the Apple Watch in the background during sleep throughout the two interventions. Values are compared between the real and sham filtration to assess the effect of air purification. Unit: number of breaths per minute

    Time frame: During each 2-week intervention (real and sham filtration); 1-week washout period is excluded

  6. Sleep Stages Durations Changes

    Nightly duration of sleep stages (Core, Deep, REM, and Awake) is calculated by summing individual sleep samples and their respective timestamps as measured by the Apple Watch in the background during sleep throughout the interventions. Values are compared between the real and sham filtration to assess the effect of air purification. Unit: hour

    Time frame: During each 2-week intervention (real and sham filtration); 1-week washout period is excluded

07

Study locations

1 site
  • New York University Abu Dhabi
    Abu Dhabi, United Arab Emirates
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2025 to primary completion in Jun 2025, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2026
First posted
Mar 17, 2026
StartActual
Feb 9, 2025
Primary completionActual
Jun 22, 2025
CompletionActual
Jun 22, 2025
Last update
Mar 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07477834
Lead sponsor
New York University Abu Dhabi
Collaborators
IQAir AG, LUT University
Responsible party
Samreen Malik (Principal Investigator, New York University Abu Dhabi) — Principal investigator
First posted
Mar 17, 2026
Start date
Feb 9, 2025
Primary completion
Jun 22, 2025
Completion
Jun 22, 2025
Last update
Mar 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion